Altered vascular reactivity in mice made hypertensive by nitric oxide synthase inhibition

Journal of Cardiovascular Pharmacology

Volumn 46, Issue 4, 2005, Pages 438-444

  Linder, A Elizabeth ^b   Weber, David S ^b   Whitesall, Steven E ^a   D'Alecy, Louis G ^a   Webb, R Clinton ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Hypertension; Mice; Nitric oxide; Nitric oxide synthase; Vascular reactivity

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; ACETYLCHOLINE; GUANYLATE CYCLASE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME INHIBITION; HEART RATE; HYPERTENSION; IN VITRO STUDY; MALE; MEAN ARTERIAL PRESSURE; MOUSE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATORS; ENZYME INHIBITORS; HEART RATE; HYPERTENSION; INDAZOLES; MALE; MICE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROARGININE; NITROPRUSSIDE; PHENYLEPHRINE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION; VASODILATOR AGENTS;

EID: 26044443743     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000175879.14994.63     Document Type: Article

References (48)

1. Callera GE, Bendhack LM. Contribution of sarcoplasmic reticulum calcium uptake and L-type calcium channels to altered vascular responsiveness in the aorta of renal hypertensive rats. Gen Pharmacol. 1999;33:457-466.
2. Linder AE, Bendhack LM. Endothelin-1-induced contraction is impaired in the tail artery of renal hypertensive rats. Vasc Pharmacol. 2002;39:77-82.
3. Beswick RA, Zhang H, Marable D, et al. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001;37:781-786.
4. Mitchell BM, Dorrance AM, Ergul A, et al. Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension. J Cardiovasc Pharmacol. 2004;43:93-98.
5. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
6. Ignarro LJ. Nitric oxide. A novel signal transduction mechanism for transcellular communication. Hypertension. 1990;16:477-483.
7. Luscher TF, Diederich D, Weber E, et al. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988;11:573-578.
8. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202-1211.
9. Malinski T, Kapturczak M, Dayharsh J, et al. Nitric oxide synthase activity in genetic hypertension. Biochem Biophys Res Commun. 1993;194:654-658.
10. Zatz R, Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension. 1998;32:958-964.
11. Kojda G, Laursen JB, Ramasamy S, et al. Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc Res. 1999;42:206-213.
12. Huang PL, Huang Z, Mashimo H, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
13. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 1989;86:3375-3378.
14. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
15. Ribeiro MO, Antunes E, de Nucci G, et al. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension. 1992;20:298-303.
16. de Campos Grifoni S, Bendhack LM. Functional study of the [Ca2+]i signaling pathway in aortas of L-NAME-hypertensive rats. Pharmacology. 2004;70:160-168.
17. Haynes WG, Noon JP, Walker BR, et al. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11:1375-1380.
18. Kanagy NL. Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension. Am J Physiol. 1997;273:H2756-H2764.
19. Peotta VA, Vasquez EC, Meyrelles SS. Cardiovascular neural reflexes in L-NAME-induced hypertension in mice. Hypertension. 2001;38:555-559.
20. Kaikita K, Schoenhard JA, Painter CA, et al. Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition. J Mol Cell Cardiol. 2002;34:617-627.
21. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994;269:13725-13728.
22. Cunha RS, Cabrai AM, Vasquez EC. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats. Am J Hypertens. 1993;6:806-809.
23. Nelson RJ, Demas GE, Huang PL, et al. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature. 1995;378:383-386.
24. Laubach VE, Shesely EG, Smithies O, et al. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA. 1995;92:10688-10692.
25. Dowell FJ, Henrion D, Duriez M, et al. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats. Br J Pharmacol. 1996;117:341-346.
26. Moreau P, Takase H, Kung CF, et al. Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Stroke. 1995;26:1922-1928; discussion 1928-1929.
27. Shesely EG, Maeda N, Kim HS, et al. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 1996;93:13176-13181.
28. Choate JK, Danson EJ, Morris JF, et al. Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice. Am J Physiol Heart Circ Physiol. 2001;281:H2310-H2317.
29. Elvan A, Rubart M, Zipes DP. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am J Physiol. 1997;272:H263-H271.
30. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol. 1997;272:F561-F578.
31. Kobayashi N, Hara K, Watanabe S, et al. Effect of imidapril on myocardial remodeling in L-NAME-induced hypertensive rats is associated with gene expression of NOS and ACE mRNA. Am J Hypertens. 2000;13:199-207.
32. De Gennaro Colonna V, Rossoni G, Rigamonti A, et al. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats. Eur J Pharmacol. 2002;450:61-66.
33. Husain K. Physical conditioning modulates rat cardiac vascular endothelial growth factor gene expression in nitric oxide-deficient hypertension. Biochem Biophys Res Commun. 2004;320:1169-1174.
34. Sasser JM, Sullivan JC, Elmarakby AA, et al. Reduced NOS3 phosphorylation mediates reduced NO/cGMP signaling in mesenteric arteries of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 2004;43:1080-1085.
35. Luscher TF, Aarhus LL, Vanhoutte PM. Indomethacin improves the impaired endothelium-dependent relaxations in small mesenteric arteries of the spontaneously hypertensive rat. Am J Hypertens. 1990;3:55-58.
36. Sekiguchi F, Miyake Y, Kashimoto T, et al. Unaltered caffeine-induced relaxation in the aorta of stroke-prone spontaneously hypertensive rats (SHRSP). J Smooth Muscle Res. 2002;38:11-22.
37. Ulker S, McMaster D, McKeown PP, et al. Impaired activities of antioxidant enzymes elicit endothelial dysfunction in spontaneous hypertensive rats despite enhanced vascular nitric oxide generation. Cardiovasc Res. 2003;59:488-500.
38. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA. 1998;95:9220-9225.
39. Faraci FM, Sigmund CD, Shesely EG, et al. Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. Am J Physiol. 1998;274:H564-H570.
40. Lake-Bruse KD, Faraci FM, Shesely EG, et al. Gene transfer of endothelial nitric oxide synthase (eNOS) in eNOS-deficient mice. Am J Physiol. 1999;277:H770-H776.
41. Brandes RP, Kim D, Schmitz-Winnenthal FH, et al. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension. 2000;35:231-236.
42. Shirasaki Y, Su C. Endothelium removal augments vasodilation by sodium nitroprusside and sodium nitrite. Eur J Pharmacol. 1985;114:93-96.
43. Busse R, Pohl U, Mulsch A, et al. Modulation of the vasodilator action of SIN-1 by the endothelium. J Cardiovasc Pharmacol. 1989;14(Suppl 11): S81-S85.
44. Moncada S, Rees DD, Schulz R, et al. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA. 1991;88:2166-2170.
45. Rothermund L, Friebe A, Paul M, et al. Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br J Pharmacol. 2000;130:205-208.
46. Lyons D, Roy S, Patel M, et al. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci (Lond). 1997;93:519-525.
47. Nascimento CA, Kauser K, Rubanyi GM. Effect of 17beta-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction. Am J Physiol. 1999;276:H1788-H1794.
48. Darblade B, Caillaud D, Poirot M, et al. Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res. 2001;50:566-576.